Kaitlyn Zenner

Kaitlyn Zenner

Auto-generated profile, based on publicly available information

Kaitlyn Zenner

Division of Pediatric Otolaryngology, Cincinnati Children's Hospital Medical Center, 3333 Burnett Ave, Cincinnati, OH, 45229, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in JCI Insight
Verified
Journal Article
Closed access
PDF file
KZKaitlyn Zenner
Kaitlyn Zenner
CCChi Vicky Cheng
Chi Vicky Cheng
DJDana M. Jensen
Dana M. Jensen
ATAndrew E. Timms
Andrew E. Timms
GSGiridhar Shivaram
Giridhar Shivaram
JBJames T. Bennett
James T. Bennett
Lymphatic malformations (LMs) are congenital, nonneoplastic vascular malformations associated with postzygotic activating PIK3CA mutations. The mutation spectrum within LMs is narrow, with the majority having 1 of 3 hotspot mutations. Despite this relative genetic homogeneity, clinical presentations differ dramatically. We used molecular inversion probes and droplet digital polymerase chain reaction to perform deep, targeted sequencing of PIK3CA in 271 affected and unaffected tissue samples from 81 individuals with isolated LMs and retrospectively collected clinical data. Pathogenic PIK3CA mutations were identified in affected LM tissue in 64 individuals (79%) with isolated LMs, with variant allele fractions (VAFs) ranging from 0.1% to 13%. Initial analyses revealed no correlation between VAF and phenotype variables. Recognizing that different mutations activate PI3K to varying degrees, we developed a metric, the genotype-adjusted VAF (GVAF), to account for differences in mutation strength, and found significantly higher GVAFs in LMs with more severe clinical characteristics including orofacial location or microcystic structure. In addition to providing insight into LM pathogenesis, we believe GVAF may have broad applicability for genotype-phenotype analyses in mosaic disorders.

1 March 2015 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
CMChristina Michailidi
Christina Michailidi
MHMasamichi Hayashi
Masamichi Hayashi
SDSayantan Datta
Sayantan Datta
TSTanusree Sen
Tanusree Sen
KZKaitlyn Zenner
Kaitlyn Zenner
Mohammad Obaidul HoqueMohammad Obaidul Hoque
Mohammad Obaidul Hoque
Exposure to toxicants leads to cumulative molecular changes that overtime increase a subject's risk of developing urothelial carcinoma. To assess the impact of arsenic exposure at a time progressive manner, we developed and characterized a cell culture model and tested a panel of miRNAs in urine samples from arsenic-exposed subjects, urothelial carcinoma patients, and controls. To prepare an in vitro model, we chronically exposed an immortalized normal human bladder cell line (HUC1) to arsenic. Growth of the HUC1 cells was increased in a time-dependent manner after arsenic treatment and cellular morphology was changed. In a soft agar assay, colonies were observed only in arsenic-treated cells, and the number of colonies gradually increased with longer periods of treatment. Similarly, invaded cells in an invasion assay were observed only in arsenic-treated cells. Withdrawal of arsenic treatment for 2.5 months did not reverse the tumorigenic properties of arsenic-treated cells. Western blot analysis demonstrated decreased PTEN and increased AKT and mTOR in arsenic-treated HUC1 cells. Levels of miR-200a, miR-200b, and miR-200c were downregulated in arsenic-exposed HUC1 cells by quantitative RT-PCR. Furthermore, in human urine, miR-200c and miR-205 were inversely associated with arsenic exposure (P = 0.005 and 0.009, respectively). Expression of miR-205 discriminated cancer cases from controls with high sensitivity and specificity (AUC = 0.845). Our study suggests that exposure to arsenic rapidly induces a multifaceted dedifferentiation program and miR-205 has potential to be used as a marker of arsenic exposure as well as a maker of early urothelial carcinoma detection. Cancer Prev Res; 8(3); 208–21. ©2015 AACR.

5 August 2021 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
JBJuliana Bonilla-Velez
Juliana Bonilla-Velez
KWKathryn B. Whitlock
Kathryn B. Whitlock
SGSheila Ganti
Sheila Ganti
KZKaitlyn Zenner
Kaitlyn Zenner
CCChi Vicky Cheng
Chi Vicky Cheng
JPJonathan A. Perkins
Jonathan A. Perkins

15 November 2022 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
CRClare M. Richardson
Clare M. Richardson
KZKaitlyn Zenner
Kaitlyn Zenner
CBCatherine Bull
Catherine Bull
ELErika Lutsky
Erika Lutsky
DJDana M. Jensen
Dana M. Jensen
JPJonathan A. Perkins
Jonathan A. Perkins

22 January 2019 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
KZKaitlyn Zenner
Kaitlyn Zenner
JDJohn Dahl
John Dahl
GDGail Deutsch
Gail Deutsch
ERErin Rudzinski
Erin Rudzinski
RBRandall Bly
Randall Bly
JPJonathan A. Perkins
Jonathan A. Perkins

16 October 2024 in International Journal of Medical Students
Verified
Journal Article
Open access
PDF file
CACaleb M. Allred
Caleb M. Allred
KZKaitlyn B. Zenner
Kaitlyn B. Zenner
JBJuliana Bonilla-Velez
Juliana Bonilla-Velez
A basic understanding of vascular anomalies will aid physicians-in-training as they seek to properly diagnose and determine interventions for these patient presentations. The aim of this review is to create a resource for physicians in training that encompasses the most important clinical aspects of vascular anomalies. Vascular anomalies of the head and neck are divided into two categories: vascular tumors and vascular malformations. This review will first describe vascular tumors followed by vascular malformations. This review discusses major pathology found in both categories of vascular anomaly. Vascular anomalies are frequently found in pediatric populations and can persist into adulthood, making it important for trainees to identify them on physical exam. This developing field seeks to improve form, function, and quality of life for patients with vascular anomalies and often requires a multidisciplinary approach (i.e., otolaryngology, dermatology, genetics, plastic surgery, interventional radiology). Various medical and surgical treatment options are available. A basic knowledge of these anomalies will allow for accurate, early diagnosis and appropriate intervention which can ultimately improve patient outcomes. Search Strategy and Selection Criteria: The MEDLINE/PubMed database was searched for primary research and reviews discussing various vascular anomalies which include infantile hemangioma, congenital hemangioma, pyogenic granuloma, tufted angioma, kaposiform hemangioendothelioma, capillary malformations, lymphatic malformations, venous malformations, and arteriovenous malformations. This search was conducted from 7/5/2023 to 3/21/2024.